These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17203588)

  • 61. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.
    Rey NL; Jardanhazi-Kurutz D; Terwel D; Kummer MP; Jourdan F; Didier A; Heneka MT
    Neurobiol Aging; 2012 Feb; 33(2):426.e1-11. PubMed ID: 21109328
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia.
    Bowler JV; Eliasziw M; Steenhuis R; Munoz DG; Fry R; Merskey H; Hachinski VC
    Arch Neurol; 1997 Jun; 54(6):697-703. PubMed ID: 9193204
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Designer receptors enhance memory in a mouse model of Down syndrome.
    Fortress AM; Hamlett ED; Vazey EM; Aston-Jones G; Cass WA; Boger HA; Granholm AC
    J Neurosci; 2015 Jan; 35(4):1343-53. PubMed ID: 25632113
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A case-control study of the locus coeruleus degeneration in Alzheimer's disease.
    Hou R; Beardmore R; Holmes C; Osmond C; Darekar A
    Eur Neuropsychopharmacol; 2021 Feb; 43():153-159. PubMed ID: 33431221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.
    Braun DJ; Kalinin S; Feinstein DL
    ASN Neuro; 2017; 9(2):1759091417696161. PubMed ID: 28266222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.
    Ehrenberg AJ; Nguy AK; Theofilas P; Dunlop S; Suemoto CK; Di Lorenzo Alho AT; Leite RP; Diehl Rodriguez R; Mejia MB; Rüb U; Farfel JM; de Lucena Ferretti-Rebustini RE; Nascimento CF; Nitrini R; Pasquallucci CA; Jacob-Filho W; Miller B; Seeley WW; Heinsen H; Grinberg LT
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):393-408. PubMed ID: 28117917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical Lewy body dementia and the impact of vascular components.
    Londos E; Passant U; Brun A; Gustafson L
    Int J Geriatr Psychiatry; 2000 Jan; 15(1):40-9. PubMed ID: 10637403
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia.
    Matthews KL; Chen CP; Esiri MM; Keene J; Minger SL; Francis PT
    Biol Psychiatry; 2002 Mar; 51(5):407-16. PubMed ID: 11904135
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.
    Del Tredici K; Braak H
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):774-83. PubMed ID: 23064099
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The pathology of the human locus ceruleus.
    Mann DM; Yates PO; Hawkes J
    Clin Neuropathol; 1983; 2(1):1-7. PubMed ID: 6220852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plaques and tangles and transmitter deficiencies in dementia.
    Mann DM; Yates PO; Hawkes J
    J Neurol Neurosurg Psychiatry; 1982 Jun; 45(6):563-4. PubMed ID: 6214616
    [No Abstract]   [Full Text] [Related]  

  • 74. Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.
    Javanshiri K; Waldö ML; Friberg N; Sjövall F; Wickerström K; Haglund M; Englund E
    J Alzheimers Dis; 2018; 65(4):1247-1258. PubMed ID: 30149459
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
    Price CC; Tanner JJ; Schmalfuss IM; Brumback B; Heilman KM; Libon DJ
    J Alzheimers Dis; 2015; 48(3):833-47. PubMed ID: 26402109
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study.
    Sjöbeck M; Haglund M; Englund E
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):919-26. PubMed ID: 16163742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
    Theofilas P; Ehrenberg AJ; Dunlop S; Di Lorenzo Alho AT; Nguy A; Leite REP; Rodriguez RD; Mejia MB; Suemoto CK; Ferretti-Rebustini REL; Polichiso L; Nascimento CF; Seeley WW; Nitrini R; Pasqualucci CA; Jacob Filho W; Rueb U; Neuhaus J; Heinsen H; Grinberg LT
    Alzheimers Dement; 2017 Mar; 13(3):236-246. PubMed ID: 27513978
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Computational Modeling of Catecholamines Dysfunction in Alzheimer's Disease at Pre-Plaque Stage.
    Caligiore D; Silvetti M; D'Amelio M; Puglisi-Allegra S; Baldassarre G
    J Alzheimers Dis; 2020; 77(1):275-290. PubMed ID: 32741822
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Brain microvessels are innervated by locus ceruleus noradrenergic neurons.
    Kalaria RN; Stockmeier CA; Harik SI
    Neurosci Lett; 1989 Feb; 97(1-2):203-8. PubMed ID: 2537480
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Noradrenergic dysfunction in Alzheimer's disease.
    Gannon M; Che P; Chen Y; Jiao K; Roberson ED; Wang Q
    Front Neurosci; 2015; 9():220. PubMed ID: 26136654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.